Crossmark

Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Crossref DOI link: https://doi.org/10.1007/s00228-023-03546-9

Published Online: 2023-08-01

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmadimoghaddam, Davoud

Talebi, Seyed Saman

Rahmani, Ayesheh

Zamanirafe, Maryam

Parvaneh, Erfan

Ranjbar, Akram

Poorolajal, Jalal

Mehrpooya, Maryam https://orcid.org/0000-0003-4119-1600
Funding

Funding for this research was provided by:

Vice-chancellor for research and technology, Hamadan University of Medical Sciences (140011199720, 140011199720, 140011199720, 140011199720, 140011199720, 140011199720, 140011199720, 140011199720)
License Information

Text and Data Mining valid from 2023-08-01

Version of Record valid from 2023-08-01
More Information

Article History

Received: 14 June 2023

Accepted: 25 July 2023

First Online: 1 August 2023

Declarations

:

: The trial protocol was in accordance with the principles of good clinical practice and the 2013 Declaration of Helsinki, and the study protocol was approved by the research and ethics committee at Hamadan University of Medical Sciences (IR.UMSHA.REC.1400.698). The participants provided their written informed consent to participate in this study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below